- ￥100 - 9999
- Biolegend
- 美国
- 329905
- 2025年07月15日
企业认证
相关产品推荐更多 >
![美天旎Miltenyi货号130-109-682大鼠CD45分选磁珠[CD45 MicroBeads(rat)]上海睿安生物13611631389](https://img1.dxycdn.com/p/s14/2025/0607/745/6714781600218331391.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
蓝冰
- 规格：
25 tests
PE anti-human CD279 (PD-1)参数介绍>>>>
| Clone | EH12.2H7 |
| Isotype | Mouse IgG1, κ |
| Reactivity | Human, Cross-Reactivity: Chimpanzee, Common Marmoset, Rhesus12, Squirrel Monkey, Cynomolgus |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA (origin USA). |
| Preparation | The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody. |
| Recommended Usage | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. Test size products are transitioning from 20 µl to 5 µl per test. Please check your vial or your CoA to find the suggested use of this reagent per million cells in 100 µl staining volume or per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application. Read more at www.biolegend.com/testsize regarding the test size change. " |
| Applications | FC - Quality tested |
| Application Notes | Additional reported applications (for the relevant formats) include: blocking of ligand binding1-3. The LEAF™ purified antibody (Endotoxin <0.1 EU/μg, Azide-Free, 0.2 μm filtered) is recommended for functional assays (Cat. No. 329911 and 329912). For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 329926) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg). " |
| Application References | 1. Dorfman DM, et al. 2006 Am. J. Surg. Pathol. 30:802. (FA) |
| Description | The program death 1 (PD-1) receptor CD279 is a 55 kD member of the immunoglobulin superfamily. CD279/PD-1 contains the immunoreceptor tyrosine-based inhibitory motif (ITIM) in the cytoplasmic region and plays a key role in peripheral tolerance and autoimmune disease. CD279/PD-1 is expressed predominantly on activated T cells, B cells and myeloid cells. PD-L1 (B7-H1) and PD-L2 (B7-DC) are ligands of CD279/PD-1 and are members of the B7 gene family. Evidence reported to date suggests overlapping functions for these two PD-1 ligands and their constitutive expression on some normal tissues and upregulation on activated antigen-presenting cells. Interaction of CD279:PD-ligands results in inhibition of T cell proliferation and cytokine secretion. |
| Storage | The CD279 antibody solution should be stored undiluted at 4°C, and protected from prolonged exposure to light. Do not freeze. |
品牌介绍：Biolegend公司自2002年成立以来，一直致力于为生物医药研究领域提供一流的，高质量的流式抗体、试剂盒及其它相关产品。公司聚集了一批来自PharMingen的专业杰出人士，建立了一支雄厚技术背景的专业队伍，并通过其自身的先天优势，以及与世界知名实验室和研究所的良好合作关系，以最合理的价格为广大客户提供卓越的免疫学和细胞生物学产品，并不断地开发新产品，以满足飞速发展的生命科学研究的需要。短短几年时间，Biolegend公司得到了飞速发展，已跻身全球最先进的抗体公司行列，并在2009年成为美国哈佛大家的独家抗体供应商！ Biolegend公司的试剂主要包括细胞免疫、细胞因子、趋化因子、粘附分子等及与癌症研究、T 调节细胞研究、干细胞研究、先天免疫研究、细胞周期分析、凋亡研究及特定修饰类抗体等领域相关的试剂，用于流式、ELISA、免疫沉淀、WB、免疫荧光、免疫组化、及体内体外功能学试验。其中，Biolegend公司的流式抗体以其具有较宽范围的荧光选择及较高的性价比，为广大科研工作者所接受！同时，公司配备了一支经验丰富的技术服务队伍，为客户提供完美的配色方案及快速的售后处理服务！
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验不只是 PD-1：CD96 正成为免疫治疗的下一个“必争之地”
, Markus Mezger.(2023). CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK Cells. [14] Chelsia Qiuxia Wang, F. C. Choy, A. Sanny, Takashi Murakami, A. Tan, K. Lam.(2023). An Inhibitory Role for Human CD96 Endodomain in T Cell Anti-Tumor
这种水果将助力癌症治疗？增强免疫治疗效果，有望克服 PD-1 耐药难题！
素 C、花青素类物质，已被证明可以通过增加肠道中嗜粘液杆菌（A.muciniphila）和双歧杆菌（Bifidobacterium）的丰度，对小鼠的肥胖和相关代谢紊乱发挥保护性作用。 2022 年 1 月 14 日，来自加拿大蒙特利尔大学研究中心的 Bertrand Routy 团队在 Cancer Discovery 上发表了题为 A natural polyphenol exerts antitumor activity and circumvents anti-PD-1 resistance
一年内两次叫停！康方CD73单抗又“悬”了，PD-1的黄金搭档还香吗？
肿瘤免疫治疗中，PD-1/L1抑制剂单药响应率有限，寻找“黄金搭档”成为焦点。CD73曾被视为最具潜力的免疫代谢靶点之一——它通过催化产生腺苷，在肿瘤微环境中形成免疫抑制屏障，阻断CD73有望“解放”T细胞，与PD-1联用实现增效。 然而理想丰满，现实骨感。2026年3月11日，外媒报道康方生物暂停了CD73单抗（drebuxelimab）联合依沃西单抗治疗非小细胞肺癌的Ib/II期研究（AK119-201），官方称“研发战略优先级调整”。这已是康方第二次叫停CD73相关试验——2025年2月
技术资料暂无技术资料 索取技术资料
